MSH3 and cancer: Moreover, MSH3 inactivation is primarily associated with instability of tetranucleotide repeats (EMAST) that has been frequently observed in moderately or poorly differentiated adenocarcinomas as well as in other cancers including lung, kidney, ovarian, and bladder cancer [14, 53].